University of Southampton:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Southampton - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9288
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Southampton (UOS) is an educational institution that offers education and research services. The institute provides educational programs in the fields of accounting and finance, acoustical engineering, aeronautics and astronautics, anthropology, archaeology, biochemistry, biology, biomedical sciences, chemistry, civil engineering, computer science and software engineering, among others. It also offers venues, catering and hospitality, and outreach and volunteering programmes for schools, and other groups. UOS partners with other universities, charities and government bodies. The institute has operations across Southampton, the UK. UOS is headquartered in Southampton, the UK.

University of Southampton – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Southampton, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Southampton, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Southampton, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
University of Southampton, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Destiny Pharma Enters into Research Collaboration with University of Southampton 10
BioInvent Enters into Research Agreement with University of Southampton 11
BioInvent And CRT Enter Into Research Agreement With University Of Southampton 12
C4X Discovery Enters Into Agreement With University of Southampton For New Cyclic Peptides 13
Licensing Agreements 14
BioInvent Enters into Licensing Agreement with University of Southampton and Cancer Research Technology 14
University of Southampton – Key Competitors 15
University of Southampton – Key Employees 16
University of Southampton – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Sep 21, 2018: Southampton gets £125k dementia research funding boost 18
Jun 05, 2018: LU receives $397,800 NIH grant for tinnitus relief research 19
May 03, 2018: New research shows that one of the most widely used treatments for childhood eczema is not helpful 21
Mar 27, 2018: A combination of cancer immunotherapies could save more lives 23
Nov 16, 2017: New talking therapy could help cancer survivors cope after treatment 25
Sep 15, 2017: ‘Exciting’ discovery on path to develop new type of vaccine to treat global viruses 26
Aug 22, 2017: Studies highlight ‘potential new targets for immunotherapy’ 28
Aug 03, 2017: Scientists deliver knock-out blow to multiple cancers 29
Aug 01, 2017: Doctors develop pioneering nose drop to help fight meningitis 30
Jul 13, 2017: Scientists make breakthrough in reversing treatment resistance in blood cancer patients 32
Product News 34
Aug 11, 2017: Experimental drug trial seeks to improve treatment for lymphoma 34
Feb 07, 2017: Researchers use tiny 3-D spheres to combat tuberculosis 36
Other Significant Developments 37
Jul 31, 2018: Blockchain-Based Pilot for Exchange of Clinical Data Announced by Grapevine World in Collaboration With the University of Southampton and Tiani Spirit 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
University of Southampton, Pharmaceuticals & Healthcare, Key Facts 2
University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Southampton, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Southampton, Deals By Therapy Area, 2012 to YTD 2018 8
University of Southampton, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Destiny Pharma Enters into Research Collaboration with University of Southampton 10
BioInvent Enters into Research Agreement with University of Southampton 11
BioInvent And CRT Enter Into Research Agreement With University Of Southampton 12
C4X Discovery Enters Into Agreement With University of Southampton For New Cyclic Peptides 13
BioInvent Enters into Licensing Agreement with University of Southampton and Cancer Research Technology 14
University of Southampton, Key Competitors 15
University of Southampton, Key Employees 16
University of Southampton, Subsidiaries 17

List of Figures
University of Southampton, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Southampton, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Southampton, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Southampton, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Southampton, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Southampton, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[University of Southampton:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alliancebernstein Holding Lp:企業の戦略・SWOT・財務分析
    Alliancebernstein Holding Lp - Strategy, SWOT and Corporate Finance Report Summary Alliancebernstein Holding Lp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Dexia Group:戦略・SWOT・企業財務分析
    Dexia Group - Strategy, SWOT and Corporate Finance Report Summary Dexia Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Wynn Macau Ltd:戦略・SWOT・企業財務分析
    Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report Summary Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • CME Group Inc:企業のM&A・事業提携・投資動向
    CME Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CME Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • U.S. Bancorp:企業の戦略・SWOT・財務情報
    U.S. Bancorp - Strategy, SWOT and Corporate Finance Report Summary U.S. Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Siemens Building Technologies:企業の戦略的SWOT分析
    Siemens Building Technologies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Duke Energy Carolinas LLC:企業の発電所・SWOT分析2018
    Duke Energy Carolinas LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Opthea Ltd (OPT):企業の財務・戦略的SWOT分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd, is a biotechnology company that develops novel biologic therapy for the treatment of eye diseases. The company carries out research and development of angiogenesis and vascular leakage-based treatments for cancer concentrating on vasc …
  • SPX Flow Inc (FLOW):企業の財務・戦略的SWOT分析
    SPX Flow Inc (FLOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Polaris Industries Inc.:企業の戦略・SWOT・財務分析
    Polaris Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Polaris Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive inform …
  • The Brookwood Partnership Ltd:企業の戦略・SWOT・財務分析
    The Brookwood Partnership Ltd - Strategy, SWOT and Corporate Finance Report Summary The Brookwood Partnership Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Gartner, Inc.:企業の戦略・SWOT・財務情報
    Gartner, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gartner, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The Interpublic Group of Companies, Inc.:企業の戦略・SWOT・財務分析
    The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Vital Therapies Inc (VTL)-医療機器分野:企業M&A・提携分析
    Summary Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute l …
  • Interprotein Corp-製薬・医療分野:企業M&A・提携分析
    Summary Interprotein Corp (Interprotein) is a drug discovery company that conducts research and develops small molecule drugs. The company provides IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E and CD94 inhibitor; KIR and HLA-C inhi …
  • The Timken Company:企業の戦略・SWOT・財務分析
    The Timken Company - Strategy, SWOT and Corporate Finance Report Summary The Timken Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cranswick plc:企業の戦略・SWOT・財務情報
    Cranswick plc - Strategy, SWOT and Corporate Finance Report Summary Cranswick plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Delong Holdings Limited:企業の戦略・SWOT・財務情報
    Delong Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Delong Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Meritor, Inc.:企業の戦略・SWOT・財務分析
    Meritor, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meritor, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆